Journal: J Med Econ 2016 Mar;:1-24
Author(s): Jemec GB, Guérin A, Kaminsky M, Okun M, Sundaram M
OBJECTIVE: Hidradenitis suppurativa (HS) is often treated by surgery. The risk of recurrence after surgery is common and the consequences are substantial, but neither has been quantified using a claims database. We aimed to estimate the burden associated with non-curative surgery in HS patients.
METHODS: We performed a retrospective analysis of health insurance claims data from Q1 1999 to Q2 2011 in a US claims database. The analysis included 2668 adults with ≥1 diagnosis of HS and ≥1 claim for skin surgery within 6 months after diagnosis. Health care resource utilization and medical costs were compared using multivariate regressions.
RESULTS: Overall, 46% of HS patients had ≥1 indicator of non-curative surgery. The incidences of inpatient, emergency department, and outpatient visits were 88%, 40%, and 30% higher, respectively, for patients with non-curative surgery versus patients without surgery (all p < 0.001). Average medical costs were $11,858 and $6427 for patients with and without indicators of non-curative surgery, respectively. The difference of $4185 (p < 0.001) was mainly driven by inpatient costs (difference = $2685; p < 0.001).
LIMITATIONS: Indicators of non-curative HS surgery were defined based on an empirical algorithm.
CONCLUSIONS: Non-curative HS surgery occurred in almost half of all cases and represents a significant burden on patients and payers in terms of resource utilization and costs.
Dermatology Journal and/or Publisher
Journal Name: Journal of medical economics
Journal Abbreviation: J Med Econ
Journal Volume: , Issue:
Journal Date Published: 2016-03-01
National Center for Biotechnology Information
PMI ID: 26938967
Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for “Hidradenitis suppurativa”Tags: Case Study Dermatology Diagnosis